MedTrace Logo

Comparison of Vasopressor Boluses for Management of Hypotension After Spinal Anesthesia

NCT03712111 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2021-09-27

No results posted yet for this study

Summary

In this study the investigators will compare the efficacy and side effects of two doses of norepinephrine bolus (6 mcg and 10 mcg) in management of maternal hypotensive episode after subarachnoid block during Cesarean delivery.

Conditions

  • Cesarean Section Complications
  • Spinal Anesthetic Toxicity

Interventions

DRUG

Norepinephrine 6 mcg

An intravenous bolus of norepinephrine 6 mcg will be administered for management of maternal hypotension.

DRUG

Norepinephrine 10 mcg

An intravenous bolus of norepinephrine 10 mcg will be administered for management of maternal hypotension.

DRUG

Bupivacaine Hydrochloride

Subarachnoid block will be performed using Bupivacaine hydrochloride (2.2 mL) in addition to fentanyl 25 mcg

DRUG

Norepinephrine infusion

Prophylactic norepinephrine infusion will be started after subarachnoid block

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed Hasanin, Professor · Assistant professor of anesthesia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-21
Primary Completion
2022-06-25
Completion
2022-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03712111 on ClinicalTrials.gov